Sales consultant covering the Americas for the MAST Automated Sampling System and the Procellics Raman system. Responsible for customer visits and support of the account managers. Driving the sales of the two products. Sold on average $3 million of products per year.

Program Management Advisor dealing with vaccine development, patented drug discovery, drug delivery, and drug stabilization technologies• Support responses to RFP and Broad Agency Announcements (BAA) to Biomedical Advanced Research and Development Authority (BARDA) dealing with Ebola vaccine development. Total value $100M.

Strategic business development.• Head of East Cost and Europe Modular Automated Sampling System (MAST) business development, installation, and maintenance. A system which collects samples from up to 10 bioreactors and delivers them to 4 plus analytical systems. Profound understanding how bioreactors work and need to be integrated.• Lead team member for transfer of Monocyte Activation Test from Europe to North America• Led portfolio of endotoxin detection products in R&D phase• Facilitate the formulation, fill and release of endotoxin detection products in a cGMP facility, getting manufacturing back on line after a shut-down.• Led the construction of a mobile clean room facility to produce "non-regulated" endotoxin detection products• Designed modular clean room facility, including an aseptic fill line (wash, depyrogenate, fill, lyophilize, visual inspect, label and package the product) using isolators.

Project Management of Data Sciences, Genetic and Bioinformatics Project• Develop and submit requisition and legal documents for external projects dealing with rare genetic disease in children and adults. Central hub for interactions between project directors, subcontractors, scientists, legal team and procurement officers. • Improved process and managed to reduce lead time from project conception to project start by over 50%.

• Analyzed portfolio of over 600 Neurotrauma projects of $1B (2001 to present) Department of Defense (DoD) investment. Investment was categorized and tracked by open/closed projects, advanced development projects, TBI severity, project type (human subjects, animal studies, technology development).• Submitted monthly Neurotrauma Report to the Office of the Surgeon General.• Developed Request for Information or Proposal (RFI/RFP) as well as MOU for Army partners.• Access Committee Member Fed. Interagency TBI Research (FITBIR) Informatics System.

• Wrote and published Statements of Work (SOW) to solicit NCI RFPs for genomic, proteomic, physical science, biospecimen and bioinformatics/IT development projects.• Chaired Source Evaluation Groups (SEG) assessing technical responses, project management plan, schedule, costs and risk of submitted proposals.• Negotiated contracts between government officials, Leidos contract/financial offices, and the subcontractors performing work. Familiar with government FAR-clauses.• Managed cost, schedules and quality of deliverables and milestones, documented project progress on different data bases, identified risks and developed risk mitigation strategies as project developed. • Executed complex simultaneous projects, including site visits to ensure performance and project adhered to standard operating protocols (SOP).• Maintained familiarity with latest scientific trends and technologies acting as Subject Matter Expert (SME) to customers in support of the development of new projects.• Prepared and presented monthly reports to NCI and Leidos senior management and organized regular meetings with government customers, to manage client expectations.

• Stakeholder Management for requirements gathering on Electronic Health Record (EHR) project.• Subject Matter Expert and liaison on scientific international outreach projects of NCI developing IT tools. Improved international interactions between software developers and scientific and medical specialists.• Developed and implemented scientific impact reviews of bioinformatics projects to communicate the needs of the scientific and clinical community to the bioinformatics and IT community.• Prepared reports to Sapient upper management and directorate of CBIIT.

• Obtaining phase 2 funding for DARPA/STO ($4M plus an additional $1M cost) Hyperadsorptive Atmospheric Sampling Technology (HAST) platform. Project controlled through budget/schedule control (EVM), and risk management. Cross matrixed, multi-location effort with over 30 personal.• Managed client expectations through regular meetings with diverse clients including Department of Defense (DoD) to discuss new business opportunities and potential projects.• Main liaison for interactions between the administrative units of DARPA, DoD and BAE Systems, such as finance, legal and contracts offices, ensuring that projects were delivered on cost and time.• Capture lead for DoD proposals, created work breakdown structure (WBS), schedule, cost, project management plans (PMP), wrote technical/scientific responses, and submitted projects.• Programs: 7-Day Biodefense (DARPA BAA 09-43), Bioinspired Photonics (DARPA BAA 09-71), Limit of Thermodynamic Storage (LOTS) of energy (DARPA BAA-10-15), Bold Quest 11 Fires on Dismounts Combat ID (Army Contracting Command). (Total Value $25M)• Presented monthly progress reports to DARPA and senior management at BAE Systems.

• Investigated the effects of trimetasphere fullerenes and other nanoparticles on cellular location and therapeutic potential in brain cancer cell lines.• Designed and executed all imaging studies and presented monthly reports to Luna Leadership.

• Coordinated the biological, engineering and bioinformatics efforts to develop a microfluidic platform to quantify signaling events in macrophages in response toxin challenges from biological threat agents.• Designed scientific studies/experiments, authored and executed all standard operating protocols (SOP).• Led drug discovery using small molecule therapies directed against bacterial and viral infections and studied toxicology of nanoparticles on immune, lung and small intestinal cells. • Steering committee member of the International Council On Nanotechnology (ICON) guiding the development and principles of nanotechnology development and science on an international level.• Prepared report to Department of Homeland Security on “Dangerous Biological Agents: An Assessment of Acquisition Strategies and Uncertainties”.• Maintained up to date knowledge of latest scientific developments in the field of biological threat agents.• Prepared and presented progress reports to senior Sandia leadership and Project Steering Committee, as well as presentation of data at international conferences.

• Optical and immunological assay development to detect intracellular signaling events in Cystic Fibrosis (CF) lung cells.• Drug discovery of small molecular treatments to correct defects in CF lung epithelial cells.• Researching bacterial infection of CF cell lines, wound healing and the kinetics of recovery.• Presenting data at international meetings and publishing papers in internationally recognized journals. This research has led to clinical trials and NIH press release.

Project development, staff supervision, presenting and publishing data. • Assay development for immunological assays (ELISA, Western Blotting) and life cell microscopy.• Studied acidification and vesicular trafficking in CF lung epithelial cells using life cell and immuno-fluorescence microscopy. All projects transferred to University of New Mexico.

Lab manager, mentor to MS students, assay development (ELISA, SDS-page), presenting and publishing data at international meetings. All projects on time and cost.• Led drug discovery to prevent S. typhimurium invasion of small intestinal cell lines and macrophages. Program funded through $500K Research Project Grant.